Brianna Taylor, LPC, TLLP | |
854 Washington Ave Ste 600, Holland, MI 49423-7141 | |
(616) 499-2218 | |
Not Available |
Full Name | Brianna Taylor |
---|---|
Gender | Female |
Speciality | Counselor - Professional |
Location | 854 Washington Ave Ste 600, Holland, Michigan |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003397266 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Brianna Taylor, LPC, TLLP 3727 Kaylee Ln, Hudsonville, MI 49426-8464 Ph: (269) 547-2131 | Brianna Taylor, LPC, TLLP 854 Washington Ave Ste 600, Holland, MI 49423-7141 Ph: (616) 499-2218 |
News Archive
Researchers at Children's Hospital Boston have found a marker called ABCB5 that both tags a small proportion of cells within colorectal cancers and fuels resistance in those cells to standard treatments. The results indicate that eliminating ABCB5-expressing cells is crucial for successful colorectal cancer treatment, while adding to the growing body of evidence for a theory of cancer growth called the cancer stem cell hypothesis.
A recent retrospective study evaluating continuous electroencephalography of children in intensive care units found a higher than anticipated number of seizures.
Actavis Inc., today began shipping Tamsulosin capsules to its customers in the United States. The generic equivalent to Flomax®, Tamsulosin is used to treat benign prostatic hyperplasia (BPH). Actavis is partnering with Synthon Pharmaceuticals to launch and market Tamsulosin capsules in the United States.
Some current therapies being investigated for Alzheimer's disease may cause further neural degeneration and cell death, according to a breakthrough discovery by UC San Diego researchers. By combining three dimensional computer simulations with high resolution atomic force microscopy membrane protein and cell imaging, electrical recording and various cellular assays, UCSD nano-biophysicist Ratnesh Lal and his colleagues investigated the structure and function of truncated peptides, known as nonamyloidgenic peptides, formed by some Alzheimer's drug candidates.
› Verified 6 days ago